Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Type 2 diabetes mellitus Age: Adult |
Dose: Oral – 25 mg Frequency: three times daily Duration: Initially, then increase if necessary after 4-8 weeks to 50 mg three times daily and continue for 3 months Note: Maximum dose: 100 mg three times daily. Hepatic Impairment: No adjustment necessary |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: No approved pediatric dosage available |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Mild-moderate renal impairment |
Dose: No dosage adjustment Note: No dosage adjustment required |
|
Condition: Severe renal impairment |
Dose: Not recommended Note: Not recommended for use in patients with severe renal impairment |
Administration
- Take with first bite of each main meal
- Must be taken with food
Side Effect
- Flatulence (42%)
- Diarrhea (29%)
- Abdominal pain (12%)
- Rash (4.3%)
- Low serum iron
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Insulin
|
Concomitant use increases the risk of hypoglycaemia
|
|
Charcoal, Amylase, Pancreatin
|
May reduce glycaemic effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Chronic Intestinal Diseases
|
Can increase gas formation
|
|
Diabetic Ketoacidosis
|
Can worsen metabolic state
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 25° C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.